OTCMKTS:BIEI

Premier Biomedical Competitors

$0.0025
0.00 (-3.85 %)
(As of 04/12/2021 03:55 PM ET)
Add
Compare
Today's Range
$0.00
Now: $0.00
$0.00
50-Day Range N/A
52-Week Range
$0.00
Now: $0.00
$0.00
Volume11.48 million shs
Average Volume22.11 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Premier Biomedical (OTCMKTS:BIEI) Vs. ABAHF, ACRGF, APPB, AYRSF, CANB, and CNTMF

Should you be buying BIEI stock or one of its competitors? Companies in the industry of "drug manufacturers - specialty & generic" are considered alternatives and competitors to Premier Biomedical, including Abacus Health Products (ABAHF), Acreage (ACRGF), Applied Biosciences (APPB), Ayr Strategies (AYRSF), Can B (CANB), and Cansortium (CNTMF).

Abacus Health Products (OTCMKTS:ABAHF) and Premier Biomedical (OTCMKTS:BIEI) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends and risk.

Analyst Recommendations

This is a breakdown of recent recommendations for Abacus Health Products and Premier Biomedical, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Abacus Health Products0000N/A
Premier Biomedical0000N/A

Earnings & Valuation

This table compares Abacus Health Products and Premier Biomedical's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Abacus Health ProductsN/AN/AN/AN/AN/A
Premier BiomedicalN/AN/AN/AN/AN/A

Profitability

This table compares Abacus Health Products and Premier Biomedical's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Abacus Health ProductsN/AN/AN/A
Premier BiomedicalN/AN/AN/A

Acreage (OTCMKTS:ACRGF) and Premier Biomedical (OTCMKTS:BIEI) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends and risk.

Earnings & Valuation

This table compares Acreage and Premier Biomedical's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AcreageN/AN/AN/AN/AN/A
Premier BiomedicalN/AN/AN/AN/AN/A

Profitability

This table compares Acreage and Premier Biomedical's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
AcreageN/AN/AN/A
Premier BiomedicalN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent recommendations for Acreage and Premier Biomedical, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Acreage01202.67
Premier Biomedical0000N/A

Acreage currently has a consensus target price of $8.4333, indicating a potential upside of 204.45%. Given Acreage's higher possible upside, equities research analysts plainly believe Acreage is more favorable than Premier Biomedical.

Summary

Acreage beats Premier Biomedical on 2 of the 2 factors compared between the two stocks.

Applied Biosciences (OTCMKTS:APPB) and Premier Biomedical (OTCMKTS:BIEI) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, dividends, institutional ownership, profitability, analyst recommendations, earnings and risk.

Earnings and Valuation

This table compares Applied Biosciences and Premier Biomedical's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Applied BiosciencesN/AN/AN/AN/AN/A
Premier BiomedicalN/AN/AN/AN/AN/A

Analyst Recommendations

This is a summary of current recommendations and price targets for Applied Biosciences and Premier Biomedical, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Applied Biosciences0000N/A
Premier Biomedical0000N/A

Profitability

This table compares Applied Biosciences and Premier Biomedical's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Applied BiosciencesN/AN/AN/A
Premier BiomedicalN/AN/AN/A

Premier Biomedical (OTCMKTS:BIEI) and Ayr Strategies (OTCMKTS:AYRSF) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, risk, dividends, earnings and valuation.

Earnings & Valuation

This table compares Premier Biomedical and Ayr Strategies' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Premier BiomedicalN/AN/AN/AN/AN/A
Ayr StrategiesN/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of current ratings and target prices for Premier Biomedical and Ayr Strategies, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Premier Biomedical0000N/A
Ayr Strategies01602.86

Ayr Strategies has a consensus price target of $34.8571, indicating a potential upside of 63.96%. Given Ayr Strategies' higher probable upside, analysts clearly believe Ayr Strategies is more favorable than Premier Biomedical.

Profitability

This table compares Premier Biomedical and Ayr Strategies' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Premier BiomedicalN/AN/AN/A
Ayr StrategiesN/AN/AN/A

Summary

Ayr Strategies beats Premier Biomedical on 2 of the 2 factors compared between the two stocks.

Premier Biomedical (OTCMKTS:BIEI) and Can B (NASDAQ:CANB) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their valuation, profitability, risk, institutional ownership, analyst recommendations, earnings and dividends.

Valuation & Earnings

This table compares Premier Biomedical and Can B's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Premier BiomedicalN/AN/AN/AN/AN/A
Can BN/AN/AN/AN/AN/A

Analyst Recommendations

This is a summary of current ratings and price targets for Premier Biomedical and Can B, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Premier Biomedical0000N/A
Can B0000N/A

Profitability

This table compares Premier Biomedical and Can B's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Premier BiomedicalN/AN/AN/A
Can BN/AN/AN/A

Premier Biomedical (OTCMKTS:BIEI) and Cansortium (OTCMKTS:CNTMF) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their valuation, profitability, risk, institutional ownership, analyst recommendations, earnings and dividends.

Analyst Recommendations

This is a summary of current ratings and price targets for Premier Biomedical and Cansortium, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Premier Biomedical0000N/A
Cansortium00103.00

Cansortium has a consensus price target of $1.20, indicating a potential upside of 43.13%. Given Cansortium's higher probable upside, analysts plainly believe Cansortium is more favorable than Premier Biomedical.

Profitability

This table compares Premier Biomedical and Cansortium's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Premier BiomedicalN/AN/AN/A
CansortiumN/AN/AN/A

Valuation & Earnings

This table compares Premier Biomedical and Cansortium's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Premier BiomedicalN/AN/AN/AN/AN/A
CansortiumN/AN/AN/AN/AN/A

Summary

Cansortium beats Premier Biomedical on 2 of the 2 factors compared between the two stocks.


Premier Biomedical Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
ABAHF
Abacus Health Products
0.4$4.84-5.4%$0.00N/A0.00Gap Up
Acreage logo
ACRGF
Acreage
1.2$2.77-0.0%$0.00N/A0.00
APPB
Applied Biosciences
0.5$0.25-0.0%$0.00N/A0.00High Trading Volume
Gap Up
AYRSF
Ayr Strategies
1.4$21.26-0.0%$0.00N/A0.00
Can B logo
CANB
Can B
0.4$0.56-1.8%$0.00N/A0.00Gap Up
Cansortium logo
CNTMF
Cansortium
1.1$0.84-1.2%$0.00N/A0.00
Charlotte's Web logo
CWBHF
Charlotte's Web
1.3$4.30-4.9%$0.00N/A0.00
Choom logo
CHOOF
Choom
0.5$0.10-0.0%$0.00N/A0.00Gap Up
CPHRF
Cipher Pharmaceuticals
1.2$1.08-0.0%$0.00N/A0.00
CLS Holdings USA logo
CLSH
CLS Holdings USA
0.7$0.22-0.0%$0.00N/A0.00Gap Down
Cosmos logo
COSM
Cosmos
0.5$5.70-1.8%$0.00N/A0.00Gap Up
Cresco Labs logo
CRLBF
Cresco Labs
1.5$12.48-2.0%$0.00N/A0.00
Curaleaf logo
CURLF
Curaleaf
1.6$14.42-1.9%$0.00N/A0.00
HMDEF
DionyMed Brands
0.5N/AN/A$0.00N/A0.00High Trading Volume
Easton Pharmaceuticals logo
EAPH
Easton Pharmaceuticals
0.5$0.00-0.0%$0.00N/A0.00Gap Down
Elixinol Global logo
ELLXF
Elixinol Global
0.8$0.15-0.0%$0.00N/A0.00Gap Down
EVIO
EVIO
0.6$0.00-0.0%$0.00N/A0.00Gap Down
Flower One logo
FLOOF
Flower One
0.4$0.28-0.0%$0.00N/A0.00Gap Up
Golden Leaf logo
GLDFF
Golden Leaf
0.5$0.05-0.0%$0.00N/A0.00Gap Down
Green Growth Brands logo
GGBXF
Green Growth Brands
0.4$0.01-0.0%$0.00N/A0.00Gap Down
Green Thumb Industries logo
GTBIF
Green Thumb Industries
1.7$28.53-1.5%$0.00N/A0.00Gap Up
GTEC logo
GGTTF
GTEC
0.6$0.61-1.6%$0.00N/A0.00News Coverage
Gap Down
Harvest Health & Recreation logo
HRVSF
Harvest Health & Recreation
1.3$2.92-4.8%$0.00N/A0.00
Hemp Naturals logo
HPMM
Hemp Naturals
0.6$0.01-0.0%$0.00N/A0.00
Hexo logo
HYYDF
Hexo
0.6$5.30-1.8%$0.00N/A0.00
Hikma Pharmaceuticals logo
HKMPY
Hikma Pharmaceuticals
0.4$59.68-0.0%$0.00N/A0.00
iAnthus Capital logo
ITHUF
iAnthus Capital
0.6$0.23-4.4%$0.00N/A0.00Gap Up
Icanic Brands logo
ICNAF
Icanic Brands
0.6$0.34-2.9%$0.00N/A0.00
KNHBF
ICC International Cannabis
0.6N/AN/A$0.00N/A0.00
Invictus MD Strategies logo
IVITF
Invictus MD Strategies
0.6$0.04-27.0%$0.00N/A0.00
Isodiol International logo
ISOLF
Isodiol International
0.4$0.05-44.4%$0.00N/A0.00Gap Down
Khiron Life Sciences logo
KHRNF
Khiron Life Sciences
1.4$0.43-4.7%$0.00N/A0.00
KHTRF
Knight Therapeutics
1.2$4.20-0.5%$0.00N/A0.00
Marijuana Company of America logo
MCOA
Marijuana Company of America
0.5$0.01-0.0%$0.00N/A0.00Gap Up
Medical Marijuana logo
MJNA
Medical Marijuana
0.6$0.05-0.0%$0.00N/A0.00
MediPharm Labs logo
MEDIF
MediPharm Labs
1.2$0.40-5.0%$0.00N/A0.00
MedMen Enterprises logo
MMNFF
MedMen Enterprises
0.8$0.35-5.7%$0.00N/A0.00Gap Down
MERCK Kommanditgesellschaft auf Aktien logo
MKKGY
MERCK Kommanditgesellschaft auf Aktien
0.5$34.83-1.4%$0.00N/A0.00
MJardin Group logo
MJARF
MJardin Group
0.9$0.08-12.0%$0.00N/A0.00Gap Up
MYHI
Mountain High Acquisitions
0.5$0.03-33.3%$0.00N/A0.00News Coverage
Gap Up
PHCEF
Pharmacielo
0.7$1.44-1.4%$0.00N/A0.00
Plus Products logo
PLPRF
Plus Products
1.1$0.55-3.6%$0.00N/A0.00
PCYN
Procyon
0.4$0.70-0.0%$0.00N/A0.00
Pure Global Cannabis logo
PRCNF
Pure Global Cannabis
0.7$0.01-4.8%$0.00N/A0.00Gap Up
SANP
Santo Mining
0.5$0.01-0.0%$0.00N/A0.00Gap Down
Shionogi & Co., Ltd. logo
SGIOY
Shionogi & Co., Ltd.
0.5$13.18-1.6%$0.00N/A0.00
DNPUF
Sumitomo Dainippon Pharma
0.5$17.40-0.0%$0.00N/A0.00
TerrAscend logo
TRSSF
TerrAscend
1.7$9.80-3.2%$0.00N/A0.00
The Flowr logo
FLWPF
The Flowr
1.5$0.25-4.0%$0.00N/A0.00
The Supreme Cannabis logo
SPRWF
The Supreme Cannabis
1.0$0.31-3.2%$0.00N/A0.00Analyst Downgrade
This page was last updated on 4/12/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected]om | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.